{"entity":{"type":"insider","cik":"0001423641","url":"/insider/0001423641","json_url":"/insider/0001423641.json","name":"MONTREUX EQUITY PARTNERS IV LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":5,"first":"2015-01-26","last":"2016-02-26","span_basis":"filed_date"},"name_variants":[{"name":"MONTREUX EQUITY PARTNERS IV LP","source":"filing","n_filings":5,"first_seen":"2015-01-26","last_seen":"2016-02-26"}],"transactions":[{"id":2947967,"accession":"0001104659-16-100505","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-100505","line_url":"/filing/0001104659-16-100505#line-1","is_derivative":false,"issuer_cik":"0001192448","issuer_name":"GLAUKOS Corp","issuer_ticker":"GKOS","issuer_name_source":null,"issuer_url":"/issuer/0001192448","owner_cik":null,"owner_name":"Montreux Equity Management IV, LLC; MONTREUX EQUITY PARTNERS IV LP; Montreux IV Associates, LLC","owner_display_name":"Montreux Equity Management IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":16.16,"price_display":"16.16","price_state":"stated","total_value":1131200.0,"total_display":"1,131,200.00","total_whole":"1,131,200","shares_owned_after":3209812.0,"shares_owned_after_display":"3,209,812","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-26","scope":"insider"},{"id":8940173,"accession":"0001104659-15-007692","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-007692","line_url":"/filing/0001104659-15-007692#line-2","is_derivative":false,"issuer_cik":"0001135906","issuer_name":"EPIRUS Biopharmaceuticals, Inc.","issuer_ticker":"EPRS","issuer_name_source":null,"issuer_url":"/issuer/0001135906","owner_cik":null,"owner_name":"Montreux Equity Partners V, L.P.; MONTREUX EQUITY PARTNERS IV LP","owner_display_name":"Montreux Equity Partners V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":5.0093,"price_display":"5.01","price_state":"stated","total_value":500930.0,"total_display":"500,930.00","total_whole":"500,930","shares_owned_after":1671400.0,"shares_owned_after_display":"1,671,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-06","filed_date":"2015-02-09","scope":"insider"},{"id":8940171,"accession":"0001104659-15-007692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-007692","line_url":"/filing/0001104659-15-007692#line-1","is_derivative":false,"issuer_cik":"0001135906","issuer_name":"EPIRUS Biopharmaceuticals, Inc.","issuer_ticker":"EPRS","issuer_name_source":null,"issuer_url":"/issuer/0001135906","owner_cik":null,"owner_name":"Montreux Equity Partners V, L.P.; MONTREUX EQUITY PARTNERS IV LP","owner_display_name":"Montreux Equity Partners V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67316.0,"shares_display":"67,316","price_per_share":4.9742,"price_display":"4.97","price_state":"stated","total_value":334843.2472,"total_display":"334,843.25","total_whole":"334,843","shares_owned_after":1771400.0,"shares_owned_after_display":"1,771,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-05","filed_date":"2015-02-09","scope":"insider"},{"id":8356868,"accession":"0001104659-15-006930","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-006930","line_url":"/filing/0001104659-15-006930#line-2","is_derivative":false,"issuer_cik":"0001135906","issuer_name":"EPIRUS Biopharmaceuticals, Inc.","issuer_ticker":"EPRS","issuer_name_source":null,"issuer_url":"/issuer/0001135906","owner_cik":null,"owner_name":"MONTREUX EQUITY PARTNERS IV LP; Montreux Equity Partners V, L.P.","owner_display_name":"MONTREUX EQUITY PARTNERS IV LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5684.0,"shares_display":"5,684","price_per_share":4.9505,"price_display":"4.95","price_state":"stated","total_value":28138.642,"total_display":"28,138.64","total_whole":"28,139","shares_owned_after":1838716.0,"shares_owned_after_display":"1,838,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-05","scope":"insider"},{"id":8356864,"accession":"0001104659-15-006930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-006930","line_url":"/filing/0001104659-15-006930#line-1","is_derivative":false,"issuer_cik":"0001135906","issuer_name":"EPIRUS Biopharmaceuticals, Inc.","issuer_ticker":"EPRS","issuer_name_source":null,"issuer_url":"/issuer/0001135906","owner_cik":null,"owner_name":"MONTREUX EQUITY PARTNERS IV LP; Montreux Equity Partners V, L.P.","owner_display_name":"MONTREUX EQUITY PARTNERS IV LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47000.0,"shares_display":"47,000","price_per_share":4.9879,"price_display":"4.99","price_state":"stated","total_value":234431.3,"total_display":"234,431.30","total_whole":"234,431","shares_owned_after":1844400.0,"shares_owned_after_display":"1,844,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-03","filed_date":"2015-02-05","scope":"insider"},{"id":8914856,"accession":"0001104659-15-005035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-005035","line_url":"/filing/0001104659-15-005035#line-1","is_derivative":false,"issuer_cik":"0001135906","issuer_name":"EPIRUS Biopharmaceuticals, Inc.","issuer_ticker":"EPRS","issuer_name_source":null,"issuer_url":"/issuer/0001135906","owner_cik":null,"owner_name":"MONTREUX EQUITY PARTNERS IV LP; Montreux Equity Partners V, L.P.","owner_display_name":"MONTREUX EQUITY PARTNERS IV LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38516.0,"shares_display":"38,516","price_per_share":6.4675,"price_display":"6.47","price_state":"stated","total_value":249102.23,"total_display":"249,102.23","total_whole":"249,102","shares_owned_after":1891400.0,"shares_owned_after_display":"1,891,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-26","filed_date":"2015-01-28","scope":"insider"},{"id":8940167,"accession":"0001104659-15-004406","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-004406","line_url":"/filing/0001104659-15-004406#line-2","is_derivative":false,"issuer_cik":"0001135906","issuer_name":"EPIRUS Biopharmaceuticals, Inc.","issuer_ticker":"EPRS","issuer_name_source":null,"issuer_url":"/issuer/0001135906","owner_cik":null,"owner_name":"MONTREUX EQUITY PARTNERS IV LP; Montreux Equity Partners V, L.P.","owner_display_name":"MONTREUX EQUITY PARTNERS IV LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8400.0,"shares_display":"8,400","price_per_share":6.2737,"price_display":"6.27","price_state":"stated","total_value":52699.08,"total_display":"52,699.08","total_whole":"52,699","shares_owned_after":1929916.0,"shares_owned_after_display":"1,929,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-23","filed_date":"2015-01-26","scope":"insider"},{"id":8940165,"accession":"0001104659-15-004406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-004406","line_url":"/filing/0001104659-15-004406#line-1","is_derivative":false,"issuer_cik":"0001135906","issuer_name":"EPIRUS Biopharmaceuticals, Inc.","issuer_ticker":"EPRS","issuer_name_source":null,"issuer_url":"/issuer/0001135906","owner_cik":null,"owner_name":"MONTREUX EQUITY PARTNERS IV LP; Montreux Equity Partners V, L.P.","owner_display_name":"MONTREUX EQUITY PARTNERS IV LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14130.0,"shares_display":"14,130","price_per_share":6.2972,"price_display":"6.30","price_state":"stated","total_value":88979.436,"total_display":"88,979.44","total_whole":"88,979","shares_owned_after":1938316.0,"shares_owned_after_display":"1,938,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-22","filed_date":"2015-01-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001192448","name":"GLAUKOS Corp","url":"/issuer/0001192448","role":"Ten percent owner","n_filings":1,"first_seen":"2016-02-26","last_seen":"2016-02-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001135906","name":"EPIRUS Biopharmaceuticals, Inc.","url":"/issuer/0001135906","role":"Ten percent owner","n_filings":4,"first_seen":"2015-01-26","last_seen":"2015-02-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001423641","retrieved_at":"2026-08-26T04:49:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}